FDA approved TheraSphere product
Closed Pre-Solicitation Posted
- Solicitation number
- W81K0022Q0171
- Agency
- Medical Command Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Jbsa Ft Sam Houston, Texas 78234, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This notice announces the Department of the Army Medical Command's intent to award a sole source contract to Boston Scientific for FDA-approved TheraSphere doses for the treatment of primary liver cancer. TheraSphere is a liver cancer therapy utilizing radioactive microspheres and is the only FDA-approved treatment for this indication. Responses to this pre-solicitation notice shall include capability statements and be submitted by August 1, 2022 to be considered for the award, which is targeted for September 1, 2022.
There is no set-aside designated for this requirement. The applicable NAICS code is 325412 for Pharmaceutical Preparation Manufacturing with a size standard of 1,250 employees. Boston Scientific is identified as the current sole source provider given their FDA approval for this therapy. Interested parties must appropriately mark any proprietary information submitted in response.
Notice text
Notice of Intent to Award Sole Source
The Regional Health Contracting Office-Central, JBSA - Fort Sam Houston, Texas intends to award a Firm Fixed Price sole source contract to Boston Scientific under the authority of Federal Acquisition Regulation (FAR) 13.501(a)(1)(ii), sole source, for the FDA approved TheraSphere doses product, which is a liver cancer therapy that consists of millions of small glass microspheres containing radioactive Y90 and who has the only FDA approved treatment for Primary liver cancer. TheraSphere is indicated for use in radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable hepatocellular carcinoma (HCC) who can have placement of appropriately positioned hepatic arterial catheters. These supplies are needed to treat liver cancer patients in the Regional Health Command Central (RHC-C).
The applicable NAICS code for this requirement is 325412. Pharmaceutical Preparation Manufacturing. The samll business Size Standard is 1,250 employees. Award will be made on or around 1 September 2022.
The solicitation number is W81K0022Q0171 and was generated for the purposes of this notice. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. All responses shall include capability statements and shall be submitted by 1 August 2022 at 3:00PM CST to be considered by the Government. A determination by the Government not to compete the purchase order based upon responses to this notice is solely within the discretion of the Government. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature.
Wayne Shavers
wayne.shavers.civ@mail.mil
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity